Q-linea as an investment
Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.
NASDAQ Stockholm(QLINEA): Quotes are delayed 15 minutes
0.423
SEK-2.76
percentQ-linea as an investment
Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.
NASDAQ Stockholm(QLINEA): Quotes are delayed 15 minutes
0.423
SEK-2.76
percentFuture-proof Healthcare
CEO Jonas Jarvius explains how Q-linea is intimately tied to his experiences of healthcare inequity, and how Q-linea is working to ensure we have sustainable and equitable healthcare, now and in the future.
Press releases
Q-linea awarded first public tender in Belgium
Ghent University publishes ASTar study results
Q-linea announces outcome of rights issue
Q-linea AB (publ) (”Q-linea” or the “Company”) (Nasdaq Stockholm: QLINEA) announces the outcome of the Company’s rights issue of…
Read more >
Keep up to date – subscribe
Christer Samuelsson
Investor Relations
Phone: +46 18 444 36 10
Mobile: +46 70 600 15 20
.
.
.